Sign inJoin waitlistJoin the waitlist

AT

Archie Tse

Medical Oncology

Credentials: · · ·

History

Medical Oncology
Internal Medicine

Research

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
Journal of Clinical Oncology · 2005 · 904 citations
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Molecular Cancer Therapeutics · 2008 · 352 citations
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma
Journal of Clinical Oncology · 2006 · 331 citations

Gary Schwartz
14 papers
DK
David Kelsen
5 papers
RC
Richard Carvajal
5 papers · 1 as a fellow
EO
Eileen O'Reilly
4 papers
LS
Lawrence Schwartz
4 papers
Manish Shah
4 papers
Robert Lefkowitz
4 papers
NK
Nancy Kemeny
3 papers
AD
Antoine Desilets
2 papers
AK
Anuradha Khilnani
2 papers
DR
Dana Rathkopf
2 papers
DK
David Klimstra
2 papers

Grants

Targeting Cell Cycle Checkpoints in Cancer Therapeutics
National Cancer Institute · K08
Contact PI · $641.3K · Sloan-Kettering Inst Can Research
2006–2011

Clinical trials

17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2005
Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2004–2009